<img alt="" src="https://secure.perk0mean.com/184504.png" style="display:none;">
Skip to content
Request a demo
February 27, 2024

Berlinger and 4G Clinical Pave the Way to Real-Time Oversight in Clinical Trials

WELLESLEY, Mass., Feb. 27, 2024 – 4G Clinical, a global leader in randomization and trial supply management (RTSM) and supply forecasting optimization software for the life sciences industry, and Berlinger & Co. AG, with over 35 years of experience in the temperature monitoring industry and its latest development SmartSystem announce a new partnership. This strategic alliance aims to address the critical issue of lack of oversight in clinical trials, particularly in dealing with scattered temperature data and improving demand prediction capabilities.

Innovation lies at the core of this collaboration, with 4G Clinical’s expertise in clinical trial supply management and demand prediction, complemented by Berlinger & Co. AG’s Modular Real-timeTM technology. Together, these advancements seek to revolutionize the clinical trial landscape by providing real-time oversight, enabling instant decision-making, and ensuring end-to-end visibility while reducing costs.

One of the pressing challenges faced in clinical trials is the lack of effective oversight due to scattered temperature data, rendering demand prediction less capable. This challenge has significant implications for the supply manager and overall site burden, introducing uncertainties that can impact the product release, efficacy, and result in unnecessary drug wastage.

The collaboration between Berlinger and 4G Clinical is driven by a shared commitment to addressing these challenges and introducing a range of joint values that are of top priority for both organizations:

  1. Removal of Burden: The joint efforts aim to alleviate the burdens faced by supply managers and clinical trial sites, streamline processes, and enhance efficiency.
  2. Real-time Oversight: The joint efforts of 4G Clinical and Berlinger will usher in a new era of oversight for clinical trials, providing stakeholders with a clear and comprehensive view in automated real-time.
  3. Instant Decision-Making: With the introduction of instant data analytics and insights, stakeholders can make informed decisions promptly, improving overall trial management.
  4. End-to-End Visibility: The collaboration ensures end-to-end visibility, promoting transparency and accountability throughout the entire clinical trial lifecycle.
  5. Patient Safety: By addressing oversight challenges, the collaboration directly contributes to enhancing patient safety, the top priority in clinical trials.
  6. Drug Efficacy: Real-time monitoring and predictive analytics will aid in maintaining the efficacy of drugs under investigation, optimizing outcomes.
  7. Drug Wastage: The joint solutions will significantly reduce drug wastage, contributing to a more sustainable and cost-effective approach to clinical trials.

4G Clinical and Berlinger are excited about the potential impact of this strategic partnership supporting clinical trials. By combining their respective strengths, they aim to reshape industry standards, improve outcomes, and pave the way for more efficient and patient-centric approaches to drug development.


About Berlinger & Co. AG

Berlinger & Co. AG develops, produces, and distributes temperature monitoring solutions for pharmaceutical, biotechnology and research organizations. With over 30 years’ experience, Berlinger’s innovative site and in-transit temperature recording devices, along with the data management software, improve efficiency for excursion management and increase patient safety. With SmartSystem, Berlinger offers a fully integrated temperature monitoring solution based around the SmartView platform and temperature devices, allowing full integration with the customer’s IRT system.

Learn more at www.4gclinical.com.